Feedback    Advertise    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum
Primary Clarification of Very High-Density Cell Culture Harvests By Enhanced Cell Settling
Emily B. Schirmer, Michael Kuczewski, Kathryn Golden, Blanca Lain, Carissa Bragg, John Chon, Marco Cacciuttolo, Gregory Zarbis-Papastoitsis
BioProcess International, Vol. 8, No. 1, January 2010, pp. 32–39
 
Materials and Methods

We generated our cell culture harvest in-house using the XD cell culture technique (1) with PER.C6 cells producing a representative MAb (IgG1, pI = 8.3, 150 kDa). These are E1-immortalized human embryonic retinal cells described elsewhere (14). Using the XD technique, they typically reach a total density of 150–170 × 106 cells/mL (1) in 14–21 days.

Table 1 summarizes the IEX matrices we used. They were prepared by washing with four to five volumes of PBS. We used GIBCO Dulbecco's PBS 1× (catalog #14190) purchased from Invitrogen (www.invitrogen.com) as received or diluted to the desired conductivity with MilliQ water from Millipore (catalog #ZMQS6V00Y, www.millipore.com). The particle density (dry grams/mL) was determined pycnometrically. Matrices were added as a 50% (v/v) slurry in buffer unless otherwise noted.

Table 1: Summary of IEX matrices used in ECS development

For depth filtration we used two-stage filter trains from Millipore and Cuno (www.cuno.com). The Millipore train involved different grades of Millistak+HC media: a LabScale Pod primary filter containing 540 cm2 of D0HC media (catalog #MD0HC054H1) and a LabScale Pod secondary filter containing 540 cm2 of X0HC media (catalog #MX0HC054H1). Millipore depth filtration was followed by sterile filtration with two parallel AcroPak 20 filters from Pall Corporation (www.pall.com) containing 20 cm2 of 0.8/0.2-µm Supor membrane.

NOMENCLATURE
APAC: analytical protein A chromatography
CM: carboxymethyl
DEAE: diethylaminoethyl
DNA: deoxyribonucleic acid
ECS: enhanced cell settling
ELISA: enzyme-linked immunosorbent assay
g: gravitational force
HCP: host cell protein
IEX: ion exchange
MAb: monoclonal antibody
ND: not determined
PBS: phosphate-buffered saline
PEI: polyethyleninimine
pI: isoelectric point
rt-PCR: real-time polymerase chain reaction
SDS-PAGE: sodium dodecylsulfate polyacrylamide gel electrophoresis
Si-PEI: Bakerbond wide-pore PEI
TBE: Tris borate ethylenediaminetetraacetic acid (EDTA)
TFF: tangential-flow filtration
TMP: transmembrane pressure
TP: Toyopearl brand
%V: percent viability
Vpool: volume of pooled supernatant and washes
Vwork: working volume of bioreactor
XD: extreme-density (perfusion bioreactor)
Xt: total cell density

The Cuno filtration train involved different grades of ZetaPlus media: a 25-cm2 BioCap primary filter containing 10M02 media (catalog #BC0025L10M02) and a 25-cm2 BioCap secondary filter containing 60ZA05A media (catalog #BC0025L60ZA05A). Sterile filtration followed, with a Pall Acrodisc PF filter containing 2.8 cm2 of 0.8/0.2 µm Supor membrane (catalog #4187).

We chose the area of each filter based on the volume of partially clarified media to be processed and operated the filters in series, with the TMP across each filter monitored by pressure transducers. First we flushed the depth filters with ≥100 L of reverse-osmosis water for each square meter of filter area at 600 L/m2/h to wet the filter media and flush out extractables, after which we attached the sterile filters. Then we loaded partially clarified harvest at 50 L/m2/h until the TMP across any one filter reached 15 psig (or until the partially clarified harvest was fully processed). The filter trains were then flushed with 40 L of 7-mS/cm PBS for each square media of filter area and blown down with air to recover the hold-up volume.

We measured antibody titers in cell culture media samples using APAC with a PA immunodetection cartridge (catalog #2-3001-00) from Applied Biosystems (www.appliedbiosystems.com) run on a Waters 2695 separations module (www.waters.com). The mobile phase was 10 mM sodium phosphate from EMD Chemicals (catalog #SX0720, www.emdchemicals.com), 150 mM sodium chloride from Mallinckrodt (catalog #7581, www.mallinckrodt.com) at pH 8.5. The elution buffer was 12 mM hydrochloric acid from Sigma (catalog #H1758, www.sigmaaldrich.com) with 150 mM sodium chloride. HCP levels were determined with a proprietary ELISA at the quality control department of DSM Biologics (www.dsm.com). We determined DNA levels using rt-PCR with customized primers from Applied Biosystems on a StepOne instrument from the same company (catalog #4376600).

We performed several small-scale experiments to develop a method for clarifying XD cell culture by ECS. Unless otherwise noted, 20 mL of cell culture broth was added to a 50 mL conical tube. In most cases, the XD culture was diluted to a cell density of 70–80 × 106 cells/mL using 5- to 7-mS/cm PBS. We added the IEX matrix and gently mixed the suspension end-over-end for 30 seconds. After the tubes settled for 0.5–2.0 hours, we analyzed aliquots of the supernatant by APAC, HCP ELISA, and rt-PCR. Cell densities and viability were measured with a Vi-Cell XR instrument from Beckman-Coulter (www.beckmancoulter.com). Then the remaining supernatant was decanted and cell pellets washed two times with isotonic PBS.

We pooled the initial supernatant and supernatants from both washes for analysis by APAC, HCP ELISA, and rt-PCR. The percent product recovery was determined using Equation 1, the percent reduction of HCPs with Equation 2, and the percent reduction of DNA by Equation 3. Because of the high cell density of the culture, it was necessary to correct MAb, HCP, and DNA concentrations for the percent biomass. We determined biomass through centrifugation of a known volume of culture at 10,000g for five minutes and taking the biomass volume from the pellet volume after centrifugation.

 «PREVIOUS PAGE    1  |    2   |    3  |    4  |    5  |     NEXT PAGE » 
 
| | Share
The Best of GE Healthcare: Tools for vaccine processes

In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.

Register to download these two NEW application notes:

Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility

DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA


More Travel Tips from the Editor in Chief
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550